Longeveron Inc. (LGVN): Price and Financial Metrics
LGVN Price/Volume Stats
| Current price | $1.65 | 52-week high | $14.80 |
| Prev. close | $1.60 | 52-week low | $0.77 |
| Day low | $1.59 | Volume | 294,400 |
| Day high | $1.72 | Avg. volume | 3,487,202 |
| 50-day MA | $2.01 | Dividend yield | N/A |
| 200-day MA | $2.26 | Market Cap | 24.48M |
LGVN Stock Price Chart Interactive Chart >
Longeveron Inc. (LGVN) Company Bio
Longeveron LLC is a clinical stage biotechnology company that engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. The company was founded by Joshua M. Hare and Donald M. Soffers in October 9, 2014 and is headquartered in Miami, FL.
LGVN Price Returns
| 1-mo | -11.76% |
| 3-mo | -19.12% |
| 6-mo | -14.06% |
| 1-year | -87.69% |
| 3-year | -99.02% |
| 5-year | N/A |
| YTD | -87.87% |
| 2023 | -57.76% |
| 2022 | -73.32% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...